Refresh
Exchange Announcement • 01 Apr 2024 19:30
Exchange Announcement • 23 Feb 2024 05:44
Exchange Announcement • 21 Feb 2024 05:05
Exchange Announcement • 29 Jan 2024 21:45
Exchange Announcement • 24 Jan 2024 06:47
ENTITY
Alaunos Therapeutics (TCRT US)
Alaunos Therapeutics (TCRT US)
1
Analysis
Health Care • United States
Alaunos Therapeutics Inc. operates as a clinical stage cellular immuno-oncology company. The Company focuses on the treatment of solid tumors through adoptive TCR-T cell therapy. Alaunos Therapeutics serves customers worldwide.
more
x